| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/17/2010 | EP2049092B1 Compositions with enhanced elasticizing activity |
| 02/17/2010 | EP1888046B1 Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles |
| 02/17/2010 | EP1750668B1 Liquids containing suspended glass particles |
| 02/17/2010 | EP1678104B1 Process for producing 1-octene from butadiene in the presence of titanium catalysts |
| 02/17/2010 | EP1648551B1 Device for improving the permeability of the human skin |
| 02/17/2010 | EP1594459B1 Drug delivery from rapid gelling polymer composition |
| 02/17/2010 | EP1549322B1 Lipid a and other carbohydrate ligand analogs |
| 02/17/2010 | EP1420775B1 Platinum complexes and their uses in therapy |
| 02/17/2010 | EP1304384B1 Biodegradable articles obtained from enzymatically synthesized amylose |
| 02/17/2010 | CN201404487Y Integrated soft capsule |
| 02/17/2010 | CN201404486Y Controlled-release micro sphere of chitosan coating 3,5-dyhydroxy-4-isopropyl toluylene |
| 02/17/2010 | CN101652129A Agent for oral administration and method for producing the same |
| 02/17/2010 | CN101652128A Sustained release compositions using wax-like materials |
| 02/17/2010 | CN101652127A Particles for cell targeting |
| 02/17/2010 | CN101652126A Multistage delivery of active agents |
| 02/17/2010 | CN101652125A Pharmaceutical composition comprising a campothecin derivative |
| 02/17/2010 | CN101652124A Increased effectiveness of allylamine drug compounds |
| 02/17/2010 | CN101652123A Stable pharmaceutical drug aerosols |
| 02/17/2010 | CN101647789A Levetiracetam slow release pellet capsule preparation and preparation method thereof |
| 02/17/2010 | CN101647788A Florfenicol microcapsule and preparation method thereof |
| 02/17/2010 | CN101647787A Carbamazepine controlled-release tablet and preparation method thereof |
| 02/17/2010 | CN101647786A Aciclovir sustained-release tablet and preparation method thereof |
| 02/17/2010 | CN101647785A Gliclazide sustained-release tablet and preparation method thereof |
| 02/17/2010 | CN101647784A Carbamazepine sustained-release tablet and preparation method thereof |
| 02/17/2010 | CN101647783A Prefreezing method in preparing injection-used reduced glutathione with freeze drying method |
| 02/17/2010 | CN101647782A Vinpocetine oral administration self-microemulsifying pellet as well as preparation method and application thereof |
| 02/17/2010 | CN101647781A Preparation method of ligustrazine phosphate powder injection |
| 02/17/2010 | CN101647780A Core-shell type magnetic nano-composite particle based on Fe3O4 and houghite and preparation method thereof |
| 02/17/2010 | CN101647779A Novel almoxicillin sodium and clavulanate potassium compound powder preparation for injection and technology for preparing same |
| 02/17/2010 | CN101647778A Preparation method of tilmicosin liposomes |
| 02/17/2010 | CN101647777A Ambroxol hydrochloride injection with small volume and preparation method thereof |
| 02/17/2010 | CN101647776A Doxofylline venous injection with small volume as well as preparation method and quality control method thereof |
| 02/17/2010 | CN101647775A Micronomicin sulfate eye drop and preparation method thereof |
| 02/17/2010 | CN101647774A Asarone injection and preparation method thereof |
| 02/17/2010 | CN101647773A Octreotide acetate injection |
| 02/17/2010 | CN101647772A Sustained release preparation for injection of LHRH antagonist substances and preparation thereof |
| 02/17/2010 | CN101647771A Silybin dihemisuccinate disodium oral preparation and preparation method thereof |
| 02/17/2010 | CN100589802C Pharmaceutical formulation of the sodium salt of telmisartan |
| 02/17/2010 | CN100589797C Extended release venlafaxine formulation |
| 02/17/2010 | CN100589796C Highly efficient delivery of large therapeutic mass aerosol |
| 02/17/2010 | CN100589795C Active foam |
| 02/17/2010 | CN100589794C Medicinal film vest medicinal film plaster for treating coronary heart disease stenocardia and preventing myocardial infaction and its preparation method |
| 02/17/2010 | CN100589793C Pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance, the system and the preparation of the enveloping substance of the system |
| 02/16/2010 | US7663057 Solution-based fabrication of photovoltaic cell |
| 02/16/2010 | US7662919 Notch-based fusion proteins and uses thereof |
| 02/16/2010 | US7662881 Base oil and an ethylene/alpha-olefin multiblock interpolymer that is a block copolymer having hard and soft segments, and unique physical properties; improved low temperature performance and flexibility in formulating motor oil, gear lubricants and greases, etc. for e.g. in cold winter performance |
| 02/16/2010 | US7662864 Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| 02/16/2010 | US7662861 Compositions containing prodrugs of florfenicol and methods of use |
| 02/16/2010 | US7662855 For treatment of skin disorders (acne); solubilized in alcohol |
| 02/16/2010 | US7662805 Mixture of antidepressant such as serotonine receptor antagonist, with acetylsalicylic acid |
| 02/16/2010 | US7662799 Powder of amino acids and method for producing the same |
| 02/16/2010 | US7662798 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
| 02/16/2010 | US7662793 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter |
| 02/16/2010 | US7662777 Particularly oral mucositis as a result of chemotherapy or radiotherapy |
| 02/16/2010 | US7662768 Transdifferentiation of pancreatic acinar cells |
| 02/16/2010 | US7662619 Addition of histidine amino acids to the cytoplasmic domains of membrane and viral envelope proteins for the purpose of solubilizing, and/or reconstituting viral envelope proteins in lipid containing vesicles |
| 02/16/2010 | US7662568 Used in highly specific and sensitive nucleic acid amplification assays; ability to detect biological toxins at sub-attomolar (10-18M) concentrations |
| 02/16/2010 | US7662413 Extracts of sacred water lotus for the treatment of cancer |
| 02/16/2010 | US7662410 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 02/16/2010 | US7662409 Biocompatible protein materials compressed with one or more biocompatible solvents to remove bulk solvent and form an interacting protein matrix material. |
| 02/16/2010 | US7662408 Sustained-release preparations |
| 02/16/2010 | US7662407 Modified release formulations of a bupropion salt |
| 02/16/2010 | US7662406 gelatin outer shell, plasticizer, starch, and antitacking agent |
| 02/16/2010 | US7662405 Comprises phosphatidyl choline, phosphatidyl glycerol, and cholesterol; for delivery to tumors |
| 02/16/2010 | US7662403 Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662369 Stabilized interferon compositions |
| 02/16/2010 | US7662313 For use as semiconductors for nanoscale electronics, optoelectronic applications in emissive devices |
| 02/16/2010 | US7662142 Sinus delivery of sustained release therapeutics |
| 02/16/2010 | US7662141 Sinus delivery of sustained release therapeutics |
| 02/16/2010 | US7662140 Method of delivering drug to brain via spinal cord |
| 02/16/2010 | US7662125 drug delivery device for wound irrigation, has reservoir housings containing water and chlorhexidine solution, and discharge nozzles; pressurized flow; used to treat a wound in the human skin and disinfection |
| 02/16/2010 | CA2462482C Oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient |
| 02/16/2010 | CA2447175C Use of estrogen compounds to increase libido in women |
| 02/16/2010 | CA2426682C Intraoral rapid-disintegrating medicinal compositions and production process thereof |
| 02/16/2010 | CA2422267C Drying method for selectively removing volatile components from wet coatings |
| 02/16/2010 | CA2421721C Therapeutic topical solution for skin and associated methods of use |
| 02/16/2010 | CA2405531C Microencapsulated fragrances and methods of coating microcapsules |
| 02/16/2010 | CA2371912C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/16/2010 | CA2368626C Cilostazol preparation |
| 02/16/2010 | CA2322641C Encapsulation of components into edible products |
| 02/16/2010 | CA2313858C Microporous films comprising flocked fibers |
| 02/16/2010 | CA2223701C Fgf9 as a specific ligand for fgfr3 |
| 02/11/2010 | WO2010017433A2 Use of sucralose as a granulating agent |
| 02/11/2010 | WO2010017432A1 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion |
| 02/11/2010 | WO2010017369A2 Macromolecular diffusion and release from self-assembled b-hairpin peptide hydrogels |
| 02/11/2010 | WO2010017361A1 Effervescent tablets/granules |
| 02/11/2010 | WO2010017348A1 Methods of using a multiple sheath flow device for the production of microcapsules |
| 02/11/2010 | WO2010017330A1 Microparticles for use in immunogenic compositions |
| 02/11/2010 | WO2010017325A2 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 02/11/2010 | WO2010017296A1 Lyophilization above collapse |
| 02/11/2010 | WO2010017273A2 Tigecycline formulations |
| 02/11/2010 | WO2010017265A2 Injectable extended release compositions and methods of treating arthritis using same |
| 02/11/2010 | WO2010017215A2 Biodegradable microspheres and methods of use thereof |
| 02/11/2010 | WO2010017152A2 Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
| 02/11/2010 | WO2010017111A1 Fast onset orodispersable tablets |
| 02/11/2010 | WO2010017056A1 Orally administered solid formulations containing a hydrophobic drug and tpgs |
| 02/11/2010 | WO2010017053A1 Solid excipient compositions |
| 02/11/2010 | WO2010016832A1 Medical devices for use in the surgical treatment of hyperproliferative diseases affecting the spinal cord |
| 02/11/2010 | WO2010016711A2 Aroma therapy patch |